Krystal Biotech Inc (KRYS)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Krish S. Krishnan
Employees:
210
2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
(412) 586-5830
Krystal Biotech, Inc. engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105, KB301, KB407, KB104, KB5xx and KB3xx product.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|